Deep Learning Algorithms for Prediction of Lymph Node Metastasis and Prognosis in Breast Cancer MRI Radiomics (RBC-01)
NCT ID: NCT04003558
Last Updated: 2019-08-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1500 participants
OBSERVATIONAL
2019-05-28
2025-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
MRI Radiomics Assessing Neoadjuvant Chemotherapy in Breast Cancer to Predict Lymph Node Metastasis and Prognosis(RBC-02)
NCT04004559
Prediction of Non-sentinel Lymph Node Metastatic Status of Breast Cancer Based on Pathology-MRI Images
NCT06510738
Deep Learning With MRI-based Multimodal-data Fusion Enhanced Postoperative Risk Stratification of Breast Cancer
NCT06546072
Prediction of Axillary Lymph Node Metastasis Status in Breast Cancer Based on PET/CT Radiomics
NCT05826197
A Study on Predicting the Risk of Distant Metastasis in Breast Cancer Using AI-Generated Spatial Pathological Maps
NCT07244094
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sun Yat-Sen Memorial Hospital of Sun Yat-sen University
The cohort of Sun Yat-Sen Memorial Hospital of Sun Yat-sen University is a training cohort.
No interventions
As this is a patient registry, there are no interventions.
Sun Yat-sen University Cancer Center
The cohort of Sun Yat-sen University Cancer Center is a validation cohort.
No interventions
As this is a patient registry, there are no interventions.
Tungwah Hospital of Sun Yat-Sen University
The cohort of Tungwah Hospital of Sun Yat-Sen University is a validation cohort.
No interventions
As this is a patient registry, there are no interventions.
Shunde hospital of southern medical university
The cohort of Shunde hospital of southern medical university is a validation cohort.
No interventions
As this is a patient registry, there are no interventions.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No interventions
As this is a patient registry, there are no interventions.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients can have regional lymph node metastasis,but no distant organ metastasis
* Complete the breast MRI examination before treatment
* Accept breast cancer surgery or lymph node biopsy
* Eastern Cooperative Oncology Group performance status 0-2
Exclusion Criteria
* Accompanied with other primary malignant tumors
* Perform surgery,radiotherapy and lymph node biopsy before breast MRI examination
* Patients who have neoadjuvant chemotherapy
* Patients had distant and contralateral axillary lymph node metastasis
* The pathologic diagnosis was extensive ductal carcinoma in situ
18 Years
75 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sun Yat-sen University
OTHER
Tungwah Hospital of Sun Yat-Sen University
UNKNOWN
Southern Medical University, China
OTHER
Zhongshan Ophthalmic Center, Sun Yat-sen University
OTHER
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Herui Yao
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Herui Yao, PhD
Role: STUDY_CHAIR
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Chuanmiao Xie, PhD
Role: PRINCIPAL_INVESTIGATOR
Sun Yat-sen University
Jie Ouyang, PhD
Role: PRINCIPAL_INVESTIGATOR
Tungwah Hospital of Sun Yat-Sen University
Qiugen Hu, PhD
Role: PRINCIPAL_INVESTIGATOR
Southern Medical University, China
Haotian Lin, PhD
Role: PRINCIPAL_INVESTIGATOR
Zhongshan Ophthalmic Center, Sun Yat-sen University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tungwah Hospital of Sun Yat-Sen University
Dongguan, Guangdong, China
Shunde hospital of southern medical university
Foshan, Guangdong, China
Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, China
Zhongshan Ophthalmic Center, Sun Yat-Sen University
Guangzhou, Guangdong, China
Sun Yat-Sen Memorial Hospital of Sun Yat-sen University
Guangzhou, Guangdong, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Yu Y, He Z, Ouyang J, Tan Y, Chen Y, Gu Y, Mao L, Ren W, Wang J, Lin L, Wu Z, Liu J, Ou Q, Hu Q, Li A, Chen K, Li C, Lu N, Li X, Su F, Liu Q, Xie C, Yao H. Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: A machine learning, multicenter study. EBioMedicine. 2021 Jul;69:103460. doi: 10.1016/j.ebiom.2021.103460. Epub 2021 Jul 4.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SYSEC-KY-KS-2019-054-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.